ArticleNeuroImage. Clinical2017
Chronic exposure to dopamine agonists affects the integrity of striatal D
Article in NeuroImage. Clinical, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 34 citations in OpenAlex.
- Targeting GPCR Signaling in Parkinson's Disease: From Molecular Pathology to Exercise-Based Therapeutics.Molecular neurobiology · 2026Review
- Single-nucleus brain transcriptomics reveals microglia dysfunction in multiple system atrophy.Nature communications · 2026Article
- Real-world evidence on levodopa dose escalation in patients with Parkinson's disease treated with istradefylline.PloS one · 2023Article
- Association Between Pathophysiological Mechanisms of Diabetic Retinopathy and Parkinson's Disease.Cellular and molecular neurobiology · 2022Review
- Transient equilibrium determination of dopamine DFrontiers in nuclear medicine · 2022Article
- Irreversible extreme freezing of gait after dopamine agonist withdrawal.Clinical case reports · 2021Article
- Towards optimising experimental quantification of persistent pain in Parkinson's disease using psychophysical testing.NPJ Parkinson's disease · 2021Review
- Synergic control of action in levodopa-naïve Parkinson's disease patients: II. Multi-muscle synergies stabilizing vertical posture.Experimental brain research · 2020Article
- Differential functional dysconnectivity of caudate nucleus subdivisions in Parkinson's disease.Aging · 2020Article
- Detecting G protein-coupled receptor complexes in postmortem human brain with proximity ligation assay and a Bayesian classifier.BioTechniques · 2020Article
- Synergic control of action in levodopa-naïve Parkinson's disease patients: I. Multi-finger interaction and coordination.Experimental brain research · 2020Article
- L-DOPA in Parkinson's Disease: Looking at the "False" Neurotransmitters and Their Meaning.International journal of molecular sciences · 2019Review
- Parkinson's disease, dopamine, and eating and weight disorders: an illness in the disease?Eating and weight disorders : EWD · 2019Article
- Compulsive eating behaviors in Parkinson's disease.Eating and weight disorders : EWD · 2019Article
- Article
- Imaging Markers of Progression in Parkinson's Disease.Movement disorders clinical practiceReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
Abstract
We aimed to investigate the integrity and clinical relevance of striatal dopamine receptor type-2 (D
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.